Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behaviour based rodent models: Evidence for the involvement of serotonergic system

被引:17
|
作者
Gautam, Baldev Kumar [1 ]
Jindal, Ankur [1 ]
Dhar, Arghya Kusum [1 ]
Mahesh, Radhakrishnan [1 ]
机构
[1] BITS, Dept Pharm, Pilani 333031, Rajasthan, India
关键词
Depression; 5-HT3 receptor antagonist; Forced swim test; Olfactory bulbectomy; PCPA; 1-(m-Chlorophenyl)-biguanide (mCPBG); OLFACTORY BULBECTOMIZED RAT; FORCED SWIMMING TEST; ANIMAL-MODELS; DEPRESSION; MICE; NOREPINEPHRINE; NEUROBIOLOGY; VENLAFAXINE; INHIBITOR; RELEASE;
D O I
10.1016/j.pbb.2013.05.006
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The present study was designed to investigate the putative antidepressant-like activity of 7a, a 5-HT3 receptor antagonist, (although indirect evidence of 5-HT3 antagonism) with an optimal log P (3.35) and pA(2) value (7.6) greater than ondansetron (pA(2) - 6.6) using behavioural tests battery of depression. Acute treatment of 7a (0.5-2 mg/kg, i.p.) in mice produced antidepressant-like effects in forced swim test (FST) and tail suspension test (TST) without affecting the baseline locomotion in actophotometer test in mice. Moreover, the combination of a sub-effective dose of 7a (025 mg/kg, i.p.) and fluoxetine (5 mg/kg, i.p.) produced an anti-immobility effect in mouse FST. Pre-treatment of mice with p-chlorophenylalanine methyl ester (PCPA; 100 mg/kg, i.p., an inhibitor of serotonin (5-HT) synthesis, for 4 consecutive days) and 1-(m-Chlorophenyl)-biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT3 receptor agonist) prevented the anti-immobility effects of 7a (2 mg/kg, i.p.) in the mouse PSI. In addition, 7a (0.5-2 mg/kg, i.p.) treatment also potentiated the 5-hydroxytryptophan (5-HTP) and pargyline induced head twitch response in mice. Furthermore, sub-chronic treatment (14 days) with 7a (0.5-2 mg/kg, i.p.) and paroxetine (10 mg/kg, i.p.) significantly attenuated the behavioural anomalies induced by bilateral olfactory bulbectomy in rats in a modified open field paradigm. These results suggest that the antidepressant-like action of 7a may be mediated by an interaction with the serotonergic system and this molecule should be further investigated as an alternative therapeutic approach for the treatment of depression. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 42 条
  • [1] Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT 3 receptor antagonist: An investigation in behaviour-based rodent models of depression
    Mahesh, Radhakrishnan
    Kumar, Baldev
    Jindal, Ankur
    Bhatt, Shvetank
    Devadoss, Thangaraj
    Pandey, Dilip Kumar
    INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (05) : 560 - 565
  • [2] 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carboxylic acids: Novel 5-HT3 receptor antagonists with anxiolytic-like activity in rodent behavioral models
    Mahesh, Radhakrishnan
    Dhar, Arghya Kusum
    Jindal, Ankur
    Bhatt, Shvetank
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2013, 91 (10) : 848 - 854
  • [3] Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models
    Kumar, Baldev
    Jindal, Ankur
    Pandey, Dilip Kumar
    Bhatt, Shvetank
    Devadoss, Thangaraj
    Mahesh, Radhakrishnan
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2012, 50 (09) : 625 - 632
  • [4] Design, Synthesis, and Pharmacological Evaluation of Novel 2-(4-substituted piperazin-1-yl)1, 8 Naphthyridine 3-Carboxylic Acids as 5-HT3 Receptor Antagonists for the Management of Depression
    Dhar, Arghya K.
    Mahesh, Radhakrishnan
    Jindal, Ankur
    Devadoss, Thangaraj
    Bhatt, Shvetank
    CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 84 (06) : 721 - 731
  • [5] Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2-Methoxy 1, 8 Naphthyridine 3-Carboxamides as 5-HT3 Receptor Antagonists
    Mahesh, Radhakrishnan
    Dhar, Arghya Kusum
    Jindal, Ankur
    Bhatt, Shvetank
    CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 83 (05) : 583 - 591
  • [6] Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists
    Mahesh, R
    Perumal, RV
    Pandi, PV
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (20) : 5179 - 5181
  • [7] Pharmacological and computational analysis of the involvement of the 5-HT4 receptor in the antidepressant-like effect of N-(3-(phenylselanyl) prop-2-yn-1-yl)benzamide in mice
    Besckow, Evelyn Mianes
    Pires, Camila Simoes
    Giehl, Maira Regina
    Godoi, Benhur
    Bortolatto, Cristiani Folharini
    Bruning, Cesar Augusto
    BRAIN RESEARCH, 2024, 1825
  • [8] Biotransformation of 4-fluoro-N-(1-{2-[(propan-2-yl)phenoxy]ethyl}-8-azabicyclo[3.2.1]octan-3-yl)-benzenesulfonamide, a novel potent 5-HT7 receptor antagonist with antidepressant-like and anxiolytic properties: In vitro and in silico approach
    Sloczynska, Karolina
    Wojcik-Pszczola, Katarzyna
    Canale, Vittorio
    Zmudzki, Pawel
    Zajdel, Pawel
    Pekala, Elzbieta
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2018, 32 (05)
  • [9] Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-YL)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-β-tetralonepyrrolidine-2,5-dione
    Obniska, J
    Pawlowski, M
    Kolaczkowski, M
    Czopek, A
    Duszynska, B
    Klodzinska, A
    Tatarczynska, E
    Chojnacka-Wójcik, E
    POLISH JOURNAL OF PHARMACOLOGY, 2003, 55 (04): : 553 - 557
  • [10] Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT3 receptor antagonist, in animal models of depression
    Devadoss, Thangaraj
    Pandey, Dilip K.
    Mahesh, Radhakrishnan
    Yadav, Shushil K.
    PHARMACOLOGICAL REPORTS, 2010, 62 (02) : 245 - 257